Director/PDMR Shareholding

DXS INTERNATIONAL PLC

Notification of Director / PDMR Dealing

The Board of DXS International plc (the “Company”), the AQSE Growth Market quoted clinical decision support developer and supplier of clinical decision support systems has received notification that on 30 September 2020 Mr Bob Sutcliffe, the Chairman, purchased 14,534 Ordinary Shares in the Company at a price of 6.88p per share.

Following the transaction specified above Mr Sutcliffe has a beneficial holding of 517,235 Ordinary Shares representing 1.07% of the issued share capital of the Company.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Robert Sutcliffe
2	Reason for the notification
a)	Position/status	Chairman
b)	Initial notification /Amendment	Initial
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	DXS INTERNATIONAL PLC
b)	LEI	2138001R1KEUWTXEVJ44
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of 0.33p each
	Identification code	ISIN GB00B2Q6HZ92
b)	Nature of the transaction	Purchase
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			6.88p	14,534
d)